An analysis of antibody responses to more than 90,000 viral protein fragments shows that age, biological sex, and genetic ...
Chai Discovery, a company that uses AI to predict and reprogram interactions between biochemical molecules, has secured $70 million in a Series A funding in a round led by Menlo Ventures, with an ...
A collaborative study published in Immunity from the Batista Lab and Liu Lab at the Ragon Institute, together with the Schief ...
Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...
Researchers created an AI-guided approach to redesign conventional antibodies into stable intrabodies that function inside living cells. These functional intrabodies hold potential to be applied in ...
Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an experimentally resolved structure SEOUL, South Korea, March 17, 2025 /PRNewswire/ ...
Age, biological sex, and human genetic factors influence the production of antibodies during the immune response. A team of ...
A new artificial intelligence-driven pipeline developed in a collaborative research combines protein structure prediction, ...
Over decades, antibodies have established themselves as a key therapeutic modality for a wide range of diseases. But antibodies as they are found in nature did not evolve to be used as drugs, says ...
Antibody therapeutics are a rapidly growing class of drugs used to treat infections as well as a range of diseases. Among them are cancer and autoimmunity particularly important, and the use of ...
Antibodies have evolved by nature to possess exquisite selectivity for foreign targets to elicit an effective immune response, making particularly promising strides in advancing drug development for ...
Alfa Cytology offers specialized radiolabeling and antibody-radionuclide conjugate development to advance radiopharmaceutical ...